Does Receipt of Seasonal Influenza Vaccine Predict Intention to Receive Novel H1N1 Vaccine

Evidence from a Nationally Representative Survey of U.S. Adults

Published in: Vaccine, v. 27, no. 42, Sep. 2009, p. 5732-5734

Posted on RAND.org on January 01, 2009

by Jürgen Maurer, Katherine M. Harris, Andrew M. Parker, Nicole Lurie

Read More

Access further information on this document at Vaccine

This article was published outside of RAND. The full text of the article can be found at the link above.

The authors analyze data on the intention of U.S. adults to receive novel H1N1 vaccine if available this fall, and studies the relationship between the intention to be vaccinated against novel H1N1 and the uptake of seasonal influenza vaccine last year. They surveyed a nationally representative sample of U.S. adults (n = 2067) via the Internet between May 26th and June 8th, 2009. Our results imply a vaccination rate for novel H1N1 of 49.6%, which corresponds to roughly 115 million adult vaccinations. Moreover, novel H1N1 vaccination intentions are strongly associated with seasonal influenza vaccinations, suggesting common attitudinal barriers to both vaccines.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.